RWDD2A

Model summary

A soluble adaptor that assembles repression complexes to dampen RNA polymerase II transcription. Its N-terminal interaction module and C-terminal adaptor cooperate to recruit corepressors and spliceosome-proximal factors, concentrating regulatory assemblies in nuclear bodies and maintaining cytoplasmic pools for shuttling. By scaffolding these partners, it couples transcriptional repression to RNA-processing hubs and enforces reduced transcriptional output.

Predicted Gene Ontology terms

1. 01

   I begin with the domain architecture.

   The N-terminus (residues 2–138) is covered by IPR016135 (Ubiquitin-conjugating enzyme/RWD-like homologous superfamily), and within this scaffold sits a canonical IPR006575 RWD domain from residues 11–134. RWD folds are structurally related to E2 ubiquitin-conjugating enzymes but typically function as non-catalytic protein–protein interaction modules that recruit or position partners in ubiquitin-like pathways and transcriptional control. The C-terminal half is defined by IPR059181 (RWDD2A/B, C-terminal domain, residues 155–284), which pairs with IPR010541 (Small nuclear ribonucleoprotein Prp3, C-terminal domain, residues 159–280). The Prp3-like C-terminus is a hallmark of spliceosome-associated adaptors and nuclear-body residents, biasing the protein toward nuclear RNA-processing assemblies and transcription-coupled RNA maturation. The entire polypeptide is encompassed by IPR017359 (Phomoidride biosynthesis cluster protein F-like family, residues 2–288), a family signature that reinforces a soluble, adaptor-centric architecture rather than enzymatic chemistry. The ordered layout—an N-terminal RWD interaction module followed by a Prp3-like C-terminal adaptor—creates a bipartite scaffold optimized for multivalent assembly and repression complexes.

2. 02

   This architecture dictates molecular function as protein binding (GO:0005515).

   The RWD core provides a high-affinity docking surface for regulatory partners, while the Prp3-like C-terminus extends binding specificity toward nuclear ribonucleoprotein assemblies and chromatin-associated factors. The absence of catalytic motifs and the presence of tandem interaction modules argue that regulation occurs through assembly and positioning of other macromolecules rather than direct enzymatic modification.

3. 03

   From this binding-centric mechanism, the biological process emerges as negative regulation of transcription by RNA polymerase II (GO:0000122).

   The RWD module can recruit corepressor machinery and chromatin remodelers, while the Prp3-like tail targets nuclear bodies and spliceosome-associated hubs where repression is coordinated with co-transcriptional RNA processing. By concentrating repression factors in nuclear foci and at promoter-proximal regions, the scaffold dampens Pol II-driven transcriptional output.

4. 04

   Cellular localization follows directly.

   The Prp3-like C-terminal domain and nuclear-body affinity point to nuclear body (GO:0016604) residency, consistent with assemblies that coordinate transcription and splicing. At the same time, soluble adaptor architecture without transmembrane segments supports cytoplasmic pools (GO:0005737), reflecting nucleocytoplasmic shuttling and assembly/disassembly cycles typical of regulatory scaffolds.

5. 05

   Mechanistically, I hypothesize that the N-terminal RWD domain nucleates complexes with transcriptional corepressors and ubiquitin-like pathway adaptors, while the Prp3-like C-terminus anchors the assembly within nuclear bodies and spliceosome-proximal environments.

   This causes transcriptional repression by stabilizing repressor–chromatin interfaces and by coupling repression to RNA maturation. Likely partners include corepressor complexes (e.g., HDAC-containing assemblies), nuclear-body organizers, and spliceosome-associated proteins that together enforce a repressed Pol II state and tune gene expression programs.